Assessment of a New Enhanced Xenograft in Open Maxillary Sinus Augmentation (sinus)
Clinical, Radiographic and Histologic Assessment of a New Xenograft Enhanced With Hydrogel in Augmentation of the Maxillary Sinus: A Randomized Controlled Trial
Implant supported dental restorations are sometimes challenging with decreased bone height in the posterior maxilla. The goal of this study is to test an augmentation bone substitute in elevating the maxillary sinus floor; in terms of soft tissue reaction, formed bone height as well as structure.
Bone substitute will be compared to a graftless method of bone augmentation depending on participants' bodies forming bone in the defective area.
Participants will:
- Undergo lateral maxillary sinus floor elevation with bone substitute or graftless method.
- Record postoperative swelling and pain through the follow up period.
- Take radiographs for evaluation of the formed bone before placing dental implants.
Descripción general del estudio
Estado
Intervención / Tratamiento
Descripción detallada
Severe atrophy of the posterior maxilla is challenging when implant supported restorations are needed. This occurs with advanced bone loss following long standing extractions along with maxillary sinus pneumatisation leading to inadequate bone height to receive a dental implant. A variety of approaches of whether to use short implants, augment the defective site along with placing an implant or even a staged approach where the atrophic site is augmented as a primary stage followed by implant placement as a secondary stage -in cases of severe atrophy- are suggested. Different techniques, as well as materials, have been proposed for augmentation of the atrophic bone to receive an endosseous implant. To date, they are both subject to continuous modifications.
Aim is to assess a novel hydrogel-enhanced xenograft material; clinically, radiographically and histologically in lateral window maxillary sinus floor elevation in a staged augmentation approach. Null hypothesis suggests that there is no significant difference between using hydrogel-enhanced xenograft material in comparison with graftless augmentation of the maxillary sinus floor in terms of tissue reaction, formed bone quantity and quality. Whereas, the alternative hypothesis claims favourability of the hydrogel-enhanced xenograft over graftless augmentation of the maxillary sinus floor.
Thirty posterior maxillary edentulous sites requiring open sinus augmentation for staged dental implant placement will be studied. Patients will be randomly allocated into two groups. Group 1 (study group) will receive a xenograft enhanced with hydrogel after Shneiderian membrane elevation. Group 2 (control group) will have stainless steel screws/pins placed buccopalatally to maintain the elevated membrane and stabilize the formed blood clot as graftless augmentation. Surgeries will be evaluated clinically in terms of pain, edema and tissue response during the follow up period. Radiographic assessment will be performed during the surgical follow-up period and after 8 months; to evaluate the formed bone height and density using CBCT. After 8 months a cylindrical bone core using a trephine bur will be taken from the augmented site, this osteotomy will be further prepared to receive the implant. Bone cores from both groups will be examined histologically.
Tipo de estudio
Inscripción (Estimado)
Fase
- Fase 2
- Fase 3
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Ramy H El Shater, MDS
- Número de teléfono: +201014111431
- Correo electrónico: ramy.hamdy@miuegypt.edu.eg
Ubicaciones de estudio
-
-
-
Ismailia, Egipto
- Reclutamiento
- Suez Canal University
-
Contacto:
- Mohamed El Sholqamy, Professor
- Número de teléfono: 00201014111431
- Correo electrónico: ramy.hamdy@miuegypt.edu.eg
-
Contacto:
- Ramy El Shater, Assistant Lecturer
- Número de teléfono: 00201014111431
-
-
Ismailia Governorate
-
Ismailia, Ismailia Governorate, Egipto, 41522
- Reclutamiento
- Suez Canal University
-
Contacto:
- El Sholqamy, Professor
- Número de teléfono: +20643205208
- Correo electrónico: president_office@suez.edu.eg
-
Contacto:
- Ramy, Assistant Lecturer
- Número de teléfono: +201014111431
- Correo electrónico: ramy.hamdy@miuegypt.edu.eg
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
Descripción
Inclusion Criteria:
- Adult male/female patients above the age of 18.
- Patients with one or more teeth requiring implant supported dental restoration in atrophic posterior maxilla.
- Alveolar bone height less than 5 mm at the defective site.
- Good oral hygiene.
- Patient's consensual agreement to be enrolled in the study.
Exclusion Criteria:
- Medically compromised patients with conditions contraindicating surgery (eg. uncontrolled diabetics, bisphosphonate intake, radio or chemotherapy).
- Patients with active infection at or related to the site of surgery (eg. acute sinusitis).
- Heavy smokers.
- Patients not indicated for an implant supported restoration at the time of enrollement.
(Patients developing any medical condition that interferes with the outcomes after enrolment in the study will be excluded).
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Triple
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Comparador activo: control group
maxillary sinus membrane is elevated through a lateral window and held in place with screws buccopalatally, similar to tenting.
|
graftless augmentation of the maxillary sinus floor through membrane elevation and stabilization; tenting.
Otros nombres:
|
|
Experimental: study group
enhanced xenograft will be used to augment the maxillary sinus floor
|
hydrogel-enhanced xenograft
Otros nombres:
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
bone height gain
Periodo de tiempo: 8 months
|
radiographically, through CBCT
|
8 months
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
patient centered edema measurement
Periodo de tiempo: 0-7 days
|
linear measurements between specific reference points on the face
|
0-7 days
|
|
patient reported/related edema estimate
Periodo de tiempo: 3-7 days
|
patients' assessment of swelling according to visual scale for edema
|
3-7 days
|
|
VAS pain
Periodo de tiempo: 10 days
|
patients' assessment of pain 0-10 daily
|
10 days
|
|
bone structure
Periodo de tiempo: 8 months
|
histological examination of harvested bone under microscope
|
8 months
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Estimado)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
- maxillary sinus pneumatization.
- severe posterior maxillary ridge atrophy.
- inadequate residual bone height.
- open sinus augmentation.
- lateral maxillary sinus floor elevation.
- tenting of the Schneiderian membrane.
- staged maxillary sinus floor augmentation and implant placement.
- modified xenografts.
- graftless augmentation.
- bone augmentation.
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 2025/ 939
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
producto fabricado y exportado desde los EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .